Omalizumab in the treatment of hyper-IgE syndrome: 2 case reports

Gomes, Nuno; Miranda, J; Lopes, S; Carneiro-Leão, L; Torres Costa, J; Baudrier, T; Azevedo, F

Gomes, Nuno; Miranda, J; Lopes, S; Carneiro-Leão, L; Torres Costa, J; Baudrier, T; Azevedo, F.

Affiliation

Gomes, Nuno; Centro Hospitalar Universitário de São João. Dermatovenereology Department. Porto. Portugal
Miranda, J; Centro Hospitalar Universitário de São João. Allergy and Clinical Immunology Department. Porto. Portugal
Lopes, S; Centro Hospitalar Universitário de São João. Dermatovenereology Department. Porto. Portugal
Carneiro-Leão, L; Centro Hospitalar Universitário de São João. Allergy and Clinical Immunology Department. Porto. Portugal
Torres Costa, J; Centro Hospitalar Universitário de São João. Allergy and Clinical Immunology Department. Porto. Portugal
Baudrier, T; Centro Hospitalar Universitário de São João. Dermatovenereology Department. Porto. Portugal
Azevedo, F; Centro Hospitalar Universitário de São João. Dermatovenereology Department. Porto. Portugal

J. investig. allergol. clin. immunol ; 30(3): 191-192, 2020. tab

Article in English | IBECS | ID: ibc-195171

Responsible library: ES1.1

Localization: BNCS

ABSTRACT

ABSTRACT

No disponible

Subject(s)

Humans; Male; Adult; Hypersensitivity, Immediate/drug therapy; Anti-Allergic Agents/therapeutic use; Omalizumab/therapeutic use; Treatment Outcome; Follow-Up Studies

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Anti-Allergic Agents / Omalizumab / Hypersensitivity, Immediate Limits: Adult / Humans / Male Language: English Journal: J. investig. allergol. clin. immunol Year: 2020 Document type: Article Institution/Affiliation country: Centro Hospitalar Universitário de São João/Portugal

Fulltext

Add to My VHL

XML

Search on Google